share_log

基石藥業-B:自願公告 - 基石藥業宣佈泰吉華(阿伐替尼片)被納入2023年國家醫保藥品目錄

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES INCLUSION OF AYVAKIT (AVAPRITINIB) IN 2023 CHINA''S NATIONAL REIMBURSEMENT DRUG LIST

香港交易所 ·  Dec 12, 2023 23:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more